Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,681 | 4,081 | -10,532 | -30,359 | -15,492 |
| Depreciation Amortization | 1 | 1 | 419 | 91 | 73 |
| Accounts receivable | 581 | -391 | -605 | -227 | -455 |
| Other Working Capital | 3,240 | -11 | -223 | 417 | -19 |
| Other Operating Activity | -8,112 | -4,026 | 6,986 | 27,739 | 14,036 |
| Operating Cash Flow | $1,391 | $-346 | $-3,955 | $-2,339 | $-1,857 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -13 | -15 | -15 |
| Investing Cash Flow | $N/A | $N/A | $-13 | $-15 | $-15 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -2,750 | N/A | N/A |
| Common Stock Issued | 11 | N/A | N/A | N/A | 0 |
| Other Financing Activity | 0 | 0 | 4,654 | 0 | 0 |
| Financing Cash Flow | $11 | $N/A | $1,904 | $N/A | $0 |
| Beginning Cash Position | 396 | 396 | 2,460 | 2,460 | 2,460 |
| End Cash Position | 1,798 | 50 | 396 | 106 | 588 |
| Net Cash Flow | $1,402 | $-346 | $-2,064 | $-2,354 | $-1,872 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,391 | -346 | -3,955 | -2,339 | -1,857 |
| Capital Expenditure | N/A | N/A | -13 | -15 | -15 |
| Free Cash Flow | 1,391 | -346 | -3,968 | -2,354 | -1,872 |